sodium caproamphoacetate hamilelikte güvenli mi?
No harmonised CLP reproductive classifications (no H360/H361) and no SCCS/CIR safety assessment indicating reproductive hazard for sodium caproamphoacetate; peer‑reviewed reproductive/toxicology studies specific to this CAS are not reported. As an amphoteric surfactant used topically, systemic absorption is expected to be low but measurable for adults, so exposure is scored as 1 (low). Sources searched: ECHA C&L (no harmonised classification), PubChem, CosIng, PubMed (no reproductive studies found).
Related ingredients
Frequently asked questions
- sodium caproamphoacetate hamilelikte güvenli mi?
- No harmonised CLP reproductive classifications (no H360/H361) and no SCCS/CIR safety assessment indicating reproductive hazard for sodium caproamphoacetate; peer‑reviewed reproductive/toxicology studies specific to this CAS are not reported. As an amphoteric surfactant used topically, systemic absorption is expected to be low but measurable for adults, so exposure is scored as 1 (low). Sources searched: ECHA C&L (no harmonised classification), PubChem, CosIng, PubMed (no reproductive studies found).
- sodium caproamphoacetate emzirirken güvenli mi?
- No evidence of reproductive or lactation-specific toxicity and no harmonised classification; mechanism of reproductive/lactation toxicity not described in available databases. Low but measurable dermal exposure assumed for topical use (adult e=1). Sources: ECHA C&L, PubChem, CosIng, PubMed.
- sodium caproamphoacetate bebek cildi için güvenli mi?
- No infant-specific toxicology or developmental data located and no regulatory flags for reproductive/developmental hazard. Because infant skin has higher absorption potential, the exposure score is increased by +1 compared with adults (adult e=1 → infant e=2). Typical use as a mild amphoteric surfactant supports low intrinsic hazard but higher relative exposure in 0–3 yr olds. Sources: CosIng, PubChem, ECHA C&L, PubMed (no infant studies found).
- VeriMom sodium caproamphoacetate nasıl puanlıyor?
- VeriMom sodium caproamphoacetate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte sodium caproamphoacetate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.